Erwann Rault is an expert in Radiotherapy at Centre Oscar Lambret (France). Erwann Rault has authored 26 publications, the most recent in 2025. SLR score: 50 (community average: 125). How the SLR is computed.

LeadR Profile

Erwann Rault Centre Oscar Lambret France
50 ScienceLeadR Reputation 50
Network Map

Radiotherapy

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2012 - 2025

Source: PubMed

Centre Oscar Lambret

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 26

Citations

Citations: 426 1st author: 7 Last author: 1 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Accuracy of manufacturer integrated quality control for helical radiotherapy.
PMID 40213033 — radiotherapy, quality control
Phys Imaging Radiat Oncol20250
Phase II study of I-metaiodobenzylguanidine with 5 days of topotecan for refractory or relapsed neuroblastoma: Results of the French study MIITOP.
PMID 37574821 — melphalan, diagnosis, topotecan, neuroblastoma, busulfan, neoplasms, whole-body irradiation, disease-free survival
Pediatr Blood Cancer20238
Stereotactic Radioablation for Ventricular Tachycardia in the Setting of Electrical Storm.
PMID 36074658 — tachycardia, ventricular, heart failure, arrhythmias, cardiac, defibrillators, implantable, therapeutics, catheter ablation, radiotherapy
Circ Arrhythm Electrophysiol202240
Integration of the M6 Cyberknife in the Moderato Monte Carlo platform and prediction of beam parameters using machine learning.
PMID 32007601 — research design, biophysics, algorithms, machine learning, learning
Phys Med20202
Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases.
PMID 31448234 — adrenal glands, neoplasm metastasis, therapeutics, neoplasms, disease-free survival, radiotherapy, confidence intervals, response evaluation criteria in solid tumors, progression-free survival
Front Oncol201923

LeadR Networks

Main global connection map